Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists

Bioorg Med Chem Lett. 2007 Apr 1;17(7):2031-5. doi: 10.1016/j.bmcl.2007.01.005. Epub 2007 Jan 13.

Abstract

Optimization of the biological activity for 5,6-diarylpyridines as CB1 receptor inverse agonists is described. Food intake and pharmacokinetic evaluation of 3f and 15c indicate that these compounds are effective orally active modulators of CB1.

MeSH terms

  • Animals
  • Behavior, Animal / drug effects
  • Chemistry, Pharmaceutical / methods*
  • Drug Design
  • Feeding Behavior / drug effects
  • Inhibitory Concentration 50
  • Models, Chemical
  • Molecular Conformation
  • Pyridines / chemical synthesis*
  • Pyridines / chemistry*
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Cannabinoid, CB1 / agonists*
  • Structure-Activity Relationship
  • Temperature
  • Toluene / chemistry

Substances

  • Pyridines
  • Receptor, Cannabinoid, CB1
  • Toluene